Award Date: IHE Mazankowski Awards awarded annually in January/May? Awards Available: Up to three (???) awards per institution annually Award Value: $2,000 Eligibility – University of Alberta: Recipients must be (full time? part time?) University of Alberta students registered/enrolled in Health Economics 000 Eligibility – University of Calgary: Recipients must be (full time? part…
Summary Report
Summary Report Coming Soon
Program
IHE/CAPT Real World Evidence Workshop – Final ProgramDownload Final Program
Sunday, 21 October 2018 Toronto, Ontario 09:00 – 09:15 Welcome and Design Sprint Overview Allan GIllman 09:15 – 10:15 Lightning Talks Rhonda Kropp, Tammy Clifford, Kelvin Chan, Michael Duong 10:15 – 10:30 Break 10:30 – 10:45 Design Challenge Statement and Case Study Presentation Dan Palfrey, Senior Consultant, Institute of Health Economics 10:45 – 12:45 Identification of Applications…
Speaker Biographies Rhonda Kropp Rhonda Kropp is currently the Director General for the Marketed Health Products Directorate in the Health Products and Food Branch of Health Canada. She is responsible for the oversight of the vigilance of marketed health products in Canada, including ensuring Canadians and health professionals are informed of important issues impacting the safety…
Facilitating innovation in the market for COPD – related services. Philip Jacobs, IHE 7/9/18 In 2016 and 2017 IHE presented two research reports on the state of the market for COPD - related services, based on research grants provided by Boehringer Ingelheim. The first report, Economic Surveillance for COPD in Alberta (available from https://www.ihe.ca/publications/economic-surveillance-for-chronic-obstructive-pulmonary-disease-copd-in-alberta),…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides Alberta small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
The IHE established its Health Technology Innovation Platform (HTIP) to enhance decision-making efficiency and improve value for money for purchasers of health technology, and to strengthen the ability for technology developers to engage in constructive policy dialogue, demonstrate the value of their technology, and improve their return on investment. The HTIP facilitates collaboration…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
Conferences are larger, standalone or serial events, hosted by the IHE or in partnership with other organizations. Various IHE Conferences have seen leading health care professionals from Canada and the United States come to Edmonton to discuss health care and health policy challenges. The IHE’s well-regarded Consensus Development Conference Series, which has seen us host international…
Knowledge Transfer & Dissemination Knowledge transfer and dissemination is an integral part of the IHE’s activities. As a neutral convenor for health policy dialogue and evidence development and dissemination, the IHE has a well-established role in facilitating and supporting the translation of knowledge into practice. Included in the IHE’s outreach and collaboration portfolio…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum Series, Roundtables…